Back to the future for antiparasite vaccines?
نویسندگان
چکیده
منابع مشابه
Stepping back to prepare for the future.
Correspondence: Nobhojit Roy, MS, MPH Jamsetji Tata Centre for Disaster Management Tata Institute of Social Sciences New Campus Deonar Farm Road Mumbai 400088 India E-mail: [email protected] Youichi Yanagawa and colleagues have candidly admitted the problems of the ‘‘Medical Evacuation of Patients to other Hospitals due to the Fukushima I Nuclear Accidents.’’ The Fukushima nuclear accident was a L...
متن کاملSerotherapy for Ebola: back to the future.
In dramatic, front-page news, Kent Brantly and Nancy Writebol, 2 American missionary workers infected with the deadly Ebola virus, were given a “highly experimental” combination of preformed monoclonal antibodies directed against the virus and previously shown to work only in monkeys. Brantly, moribund and poorly responsive to a previous blood transfusion containing convalescent antibodies, app...
متن کاملBack to the Future for Dermatophyte Genomics
Dermatophytes are a uniquely pathogenic group of fungi that cause most common fungal infections globally. The major cause of athlete's foot is Trichophyton rubrum, a pathogen of human skin. A recent paper in this journal reported the sequencing and analysis of five additional genome sequences, including that of Trichophyton rubrum. These five join the existing two additional genome sequences to...
متن کاملInfluenza vaccines for the future.
From the Division of Microbiology and Infectious Diseases (L.C.L.) and the Office of the Director (A.S.F.), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD. Address reprint requests to Dr. Lambert at the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, 6610 Rockledge Dr., Bethesda, MD 2089...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Review of Vaccines
سال: 2013
ISSN: 1476-0584,1744-8395
DOI: 10.1586/erv.12.136